Gambaran Hasil Pemeriksaan Neutrofil Limfosit Rasio, CRP dan D-Dimer Dalam Memantau Keparahan Pasien Positif Covid-19 Di Rumah Sakit Haji Jakarta Tahun 2022
Abstract
Identifikasi awal dari indikator yang membedakan pasien COVID-19 yang parah dari yang sedang dapat memfasilitasi intervensi medis yang lebih cepat seperti perawatan intensif untuk yang sakit kritis, sehingga menurunkan tingkat kematian dan mengoptimalkan penggunaan sumber daya medis. Tujuan penelitian ini adalah identifikasi dini pasien COVID-19 dengan gejala berat melalui pemeriksaan Neutrofil Limfosit rasio, CRP dan D-Dimer, sehingga pasien COVID-19 dengan gejala berat dapat ditangani lebih dini dan tidak berakhir dengan kematian. Target khusus penelitian ini untuk mengetahui bagaimana gambaran hasil pemeriksaan Neutrofil Limfosit rasio, CRP dan D-Dimer dalam memantau keparahan pasien positif COVID-19. Metode penelitian yang digunakan adalah desain cross sectional. Jumlah sampel sebanyak 108 pasien COVID-19 dengan kondisi parah berdasarkan data rekam medik periode Juni 2020-Desember 2021. Hasil penelitian menunjukkan terjadi peningkatan 82% pada hasil Netrofil Limfosit rasio (rerata 6,2), 100% pada hasil pemeriksaan CRP (rerata 34,8 mg/L) dan D-Dimer (2,5 mg/L), dengan korelasi kuat (r= 0,67) dan signifikansi hubungan 0,01 (< 0,05). Simpulan pemeriksaan Netrofil Limfosit rasio, CRP dan D-Dimer dapat digunakan untuk memprediksi tingkat keparahan pada pasien COVID-19.
Kata kunci: COVID-19, Neutrofil Limfosit rasio, CRP, D-Dimer
Full Text:
PDFReferences
Bank TW. Projected poverty impacts of COVID-19 (coronavirus). 2020 [cited 2020 21 August]; Available from: https://www.worldbank.org/en/topic/poverty/brief/projected-poverty-impacts- of-COVID-19.UN. Realization of the sustainable development goals by, for and with persons with disabilities. 2018; New YOrk: United Nations; 2018.
Belli S, Balbi B, Prince I, Cattaneo D, Masocco F, Zaccaria S, et al. Low physical functioning and impaired performance of activities of daily life in COVID-19 patients who survived the hospitalisation. Eur Respir J. 2020.
Bhaskar S, Sinha A, Banach M, Mittoo S, Weissert R, Kass JS, et al. Cytokine Storm in COVID-19-Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper. Frontiers in immunology. 2020; 11: 1648.
Carfi A, Bernabei R, Landi F, Gemelli Against C-P-ACSG. Persistent Symptoms in Patients After Acute COVID-19. Jama. 2020.
Channappanavar R, Perlman S. Evaluation of Activation and Inflammatory Activity of Myeloid Cells During Pathogenic Human Coronavirus Infection. Methods Mol Biol. 2020; 2099: 195-204.
Chowdhury MA, Hossain N, Kashem MA, Shahid MA, Alam A. Immune response in COVID-19: A review. J Infect Public Health. 2020.
COVID-19 STP. Peta Sebaran COVID-19. 2020 [cited 2020 21 AUgust]; Available from: https://covid19.go.id/peta-sebaran.
Gomez-Rial J, Rivero-Calle I, Salas A, Martinon-Torres F. Role of Monocytes/Macrophages in Covid-19 Pathogenesis: Implications for Therapy. Infect Drug Resist. 2020; 13: 2485-93.
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. New Engl J Med. 2020; published online February 28. DOI: 10.1056/NEJMoa2002032.
Helmholtz. Is it possible to predict an end to the corona crisis? 2020 [cited 202021 August]; Available from: https://www.helmholtz.de/en/health/is-it- possible-to-predict-an-end-to-the-corona-crisis/.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-50
Huang I, Pranata R, Lim MA, Oehadian A, Alisjahbana B. C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis, Ther Adv Respir Dis. 2020 Jan-Dec;14. DOI: 10.1177/1753466620937175
Lau SKP, Lau CCY, Chan KH, Li CPY, Chen H, Jin DY, et al. Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment. J Gen Virol. 2013; 94: 2679-90.
Limited, R., & African, E. (2020). Superheroes COVID-19. 20(5).
Lopez C, Closa C, Lucas E. [Telemedicine in rehabilitation: Post-COVID need and opportunity]. Rehabilitacion (Madr). 2020.
Lopez M, Bell K, Annaswamy T, Juengst S, Ifejika N. COVID-19 Guide for the Rehabilitation Clinician: A Review of Nonpulmonary Manifestations and Complications. American journal of physical medicine & rehabilitation. 2020; 99: 669-73.
Martini N, Piccinni C, Pedrini A, Maggioni A. [CoViD-19 and chronic diseases: current knowledge, future steps and the MaCroScopio project.]. Recenti Prog Med. 2020; 111: 198-201.
Milena Adina Man, Ruxandra Mioara Rajnoveanu, Nicoleta Stefania Motoc, Cosmina Loana Bondor, Ana Florica Chis, Andrea Lesan, Ruxandra Pulu, Sergiu Remus Lucaciu, Elena Dantes, Bianca Gergely Domokos, Ovidiu Fira Mladinescu, Neutrophil to Lymphocyte Ratio Platelets to Lymphocyte Ratio and Eosinophils Correlation with High Resolution Computer Tomography Severity Score in COVID-19 Patients; journal plos org, published online June 28 2021. DOI: 10.1371/journal.plos.org.
Mo P, Xing Y, Xiao Y, Deng L, Zhao Q, Wang H, et al. Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China. Clin Infect Dis. 2020; published online March 16. DOI: 10.1093/cid/ciaa270.
Nugraha B, Setyono GR, Defi IR, Gutenbrunner C. Strengthening rehabilitation services in Indonesia: A brief situation analysis. Journal of rehabilitation medicine. 2018;50: 377-84.
PAHO. Rehabilitation considerations during the COVID-19 outbreak 2020; 2020.
Pramana IGAAS, Masyuni PUS, I Dewa PS. Nilai rasio neutrofil-limfosit sebagai prediktor kasus COVID-19 serangan berat pada pasien dewasa. Intisari Sains Medis. 2021;12(2):5303.
Rehabilitation C. Cochrane rehabilitation. 2020 [cited 2020 21 August 2020]; Available from: https://rehabilitation.cochrane.org/.
RSCM. Covid-19 Clinical Practice Guideline. Jakarta: RSCM, 2020.
Sohrabi C, Alsafi Z, O'Neill N, Khan M, Kerwan A, Al-Jabir A, et al. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). Int J Surg. 2020; 76: 71-6.
Sriyanto Sriyato, Lyana Setiawan, Rizana Fajrunni’mah, Farida Murtiani. Hubungan Kadar Interleukin-6 (IL-6) dengan Neutrophil Lymphocyte Ratio (NLR) pada Pasien COVID- 19, The Indonesian Jounal of Infectious Diseases, Vol. 8 no. 01, 2022.
Susilo A, Rumede M, Pitoyo CW, Santsoso WD, Yulianti M, dkk. Coronavirus Disease 2019: Tinjauan Pustaka Terkini. Jurnal Penyakit Dalam Indonesia. 2020; 7 (1): 45-67.
Susilo, A., Rumende, C. M., Pitoyo, C. W., Santoso, W. D., Yulianti, M., Herikurniawan, H., Sinto, R., Singh, G., Nainggolan, L., Nelwan, E. J., Chen, L. K., Widhani, A., Wijaya, E., Wicaksana, B., Maksum, M., Annisa, F., Jasirwan, C. O. M., & Yunihastuti, E. (2020). Coronavirus Disease 2019: Tinjauan Literatur Terkini. Jurnal Penyakit Dalam Indonesia, 7(1), 45. https://doi.org/10.7454/jpdi.v7i1.415
Tsamarah YT, Danuyanti IGAND, Siti Z. Hubungan nilai laju endap (LED) dengan kadar CRP pada pasien positif Covid-19. Jurnal Kesehatan Andalas. 2021;10(3):173-6.
WHO. COVID-19 significantly impacts health services for noncommunicable diseases. 2020 [cited 2020 20 August]; Available from: https://www.who.int/news-room/detail/01-06-2020-covid-19-significantly- impacts-health-services-for-noncommunicable-diseases.
Worldometers.info. Covid-19 Coronavirus pandemic. 2020 [cited 2020 8 September]; Available from: https://www.worldometers.info/coronavirus/.
DOI: https://doi.org/10.37012/anakes.v9i1.1407
Refbacks
- There are currently no refbacks.
Copyright (c) 2023 Ellis Susanti
This work is licensed under a Creative Commons Attribution 4.0 International License.
Address:
Universitas Mohammad Husni Thamrin
Jl. Raya Pd. Gede No.23-25, RT.2/RW.1, Dukuh, Kec. Kramat jati, Kota Jakarta Timur, Daerah Khusus Ibukota Jakarta 13550
Anakes : Jurnal Ilmiah Analis Kesehatan is licensed under a Creative Commons Attribution 4.0 International License.
View My Stats